Michael Furlong

Associate Director, Bioanalysis @Crinetics Pharmaceuticals

Nashua, NH, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2023 — Present

Associate Director, Bioanalysis @Crinetics Pharmaceuticals

View department →

NH, US

Oversee regulated and non-regulated bioanalysis activities in the US, Canada, and China.Lead author of bioanalytical content for a successful NDA submission; PALSONIFY was approved by the FDA in 2025.Lead author on responses to bioanalytical questions from the FDA and the EMA.

EDUCATION

N/A

Wayne State University

Master of Science (MS), Pharmaceutical Sciences

N/A

Purdue University

Doctor of Philosophy (Ph.D.), Medicinal Chemistry

N/A

University of Windsor

Bachelor of Science (BSc), Chemistry and Biochemistry

SKILLS

ValidationMedicinal ChemistryChemistryOrganic SynthesisTechnology TransferGood Laboratory Practice (Glp)Regulatory SubmissionsIn VivoPeptidesCROLc-MsCRO ManagementLife SciencesDrug DeliveryLimsLiquid Chromatography-Mass Spectrometry (Lc-Ms)FormulationLifesciencesPurificationPharmacologyCell CultureOncologyProtein ChemistryBiotechnologyDmpkBioanalysisBiopharmaceuticalsPharmaceutical IndustrySopGlpIndToxicologyUv/VisIn VitroClinical TrialsOrganic Chemistry

ABOUT MICHAEL FURLONG

Experienced bioanalytical scientist, proficient in all phases of the bioanalytical (BA) lab outsourcing life cycle, including BA lab identification, pre-qualification and onboarding, operational, technical, and financial oversight of lab activities, and authoring/reviewing of bioanalytical content in regulatory submissions.Bioanalytical technical expert• LC-MS/MS bioanalysis of small molecule drug candidates, biomarkers, and monoclonal antibodies.• Hands-on LC-MS/MS laboratory and Principal Investigator experience in GLP-regulated and non-regulated Pharma, Biotech, and Contract Research Lab (CRO) environments.• Knowledgeable of key bioanalytical guidances (e.g, ICH guideline M10 on bioanalytical method validation and study sample analysis).• Lead author on numerous bioanalytical scientific publications.• Basic knowledge of ligand binding assays and molecular biology assays (PCR, sequencing).Experienced in developing and leading partnerships with bioanalytical CROs• New partnership initiation in conjunction with finance, legal, and QA colleagues, including non-disclosure agreements, master service agreements, pricing negotiations, and QA audits.• Responsible for all aspects of BA lab contracting, including review and approval, change orders, and invoice review/approval. • Conduct regular TCs with BA lab program managers to discuss progress toward deliverables and troubleshoot technical/timeline challenges as needed.Bioanalytical lead on clinical and nonclinical study and program teams• Collaboration with Clinical Pharmacology, Toxicology, Toxicokinetics, Clinical Operations, Data Management, DMPK, Quality Assurance, and other functions/vendors, to ensure that BA labs provide high quality and timely pharmacokinetic/toxicokinetic sample concentration data and reports.• Partner with medical writing and regulatory colleagues/vendors to deliver high quality BA sections of INDs, NDAs, MAAs, toxicokinetic reports, clinical study reports, etc.• Contribute to PK/TK sample collection sections of clinical site manuals and nonclinical study protocols.• Facilitate BA lab review and finalization of data transfer agreements.Working knowledge of DMPK principles, including Phase 1/II metabolic pathways, drug-drug interactions, and noncompartmental pharmacokinetic analysis/WinNonlin experience.Lab-based bioanalytical positions include Pfizer, Vertex, Absorption Systems, Lexicon Genetics, and Genelabs Technologies.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Michael Furlong — Associate Director, Bioanalysis at Crinetics Pharmaceuticals in Nashua, NH, US | Unifers